UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): May 20, 2004
AQUACELL TECHNOLOGIES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-16165 33-0750453
------------------------------ ------------- ------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
10410 Trademark Street, Rancho Cucamonga, CA 91730
---------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(909) 987-0456
--------------------------------------------------
Registrant's telephone number, including area code
ITEM 5. Other Events and Regulation FD Disclosure.
AquaCell Technologies, Inc. (the "Company") issued a letter to its
stockholders detailing the current status of the Company, its products, programs
and marketing efforts. The letter is attached as Exhibit 99.1.
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Copy of Letter to Stockholders dated May 20, 2004.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AQUACELL TECHNOLOGIES, INC.
Date: May 20, 2004 By: /s/ Gary S. Wolff
------------------------------------
Gary S. Wolff
Principal Accounting Officer